The association of body mass index with long-term clinical outcomes after ticagrelor monotherapy following abbreviated dual antiplatelet therapy in patients undergoing percutaneous coronary intervention: a prespecified sub-analysis of the GLOBAL LEADERS Trial

BACKGROUND: The efficacy of antiplatelet therapies following percutaneous coronary intervention (PCI) may be affected by body mass index (BMI). METHODS AND RESULTS: This is a prespecified subgroup analysis of the GLOBAL LEADERS trial, a prospective, multicenter, open-label, randomized controlled tri...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Res Cardiol
Main Authors: Ono, Masafumi, Chichareon, Ply, Tomaniak, Mariusz, Kawashima, Hideyuki, Takahashi, Kuniaki, Kogame, Norihiro, Modolo, Rodrigo, Hara, Hironori, Gao, Chao, Wang, Rutao, Walsh, Simon, Suryapranata, Harry, da Silva, Pedro Canas, Cotton, James, Koning, René, Akin, Ibrahim, Rensing, Benno J. W. M., Garg, Scot, Wykrzykowska, Joanna J., Piek, Jan J., Jüni, Peter, Hamm, Christian, Steg, Philippe Gabriel, Valgimigli, Marco, Windecker, Stephan, Storey, Robert F., Onuma, Yoshinobu, Vranckx, Pascal, Serruys, Patrick W.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer Berlin Heidelberg 2020
Assuntos:
Original Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7449952/
https://ncbi.nlm.nih.gov/pubmed/32006156
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s00392-020-01604-1
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados